CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 70 filers reported holding CARA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $133,000 | -8.9% | 11,025 | -4.2% | 0.00% | – |
| Q4 2021 | $146,000 | -60.5% | 11,504 | -52.1% | 0.00% | – |
| Q3 2021 | $370,000 | +19.7% | 23,998 | +13.7% | 0.00% | – |
| Q2 2021 | $309,000 | +41.1% | 21,103 | +163.7% | 0.00% | – |
| Q1 2021 | $219,000 | +19.0% | 8,004 | -28.5% | 0.00% | – |
| Q4 2020 | $184,000 | +152.1% | 11,195 | +109.6% | 0.00% | – |
| Q3 2020 | $73,000 | -24.7% | 5,340 | -2.2% | 0.00% | – |
| Q2 2020 | $97,000 | +136.6% | 5,458 | +70.8% | 0.00% | – |
| Q1 2020 | $41,000 | -92.8% | 3,195 | -90.9% | 0.00% | – |
| Q4 2019 | $566,000 | -5.7% | 35,134 | +7.1% | 0.00% | -100.0% |
| Q3 2019 | $600,000 | -13.7% | 32,817 | +1.5% | 0.00% | 0.0% |
| Q2 2019 | $695,000 | +20.0% | 32,346 | +9.6% | 0.00% | – |
| Q1 2019 | $579,000 | +48.8% | 29,505 | -1.5% | 0.00% | – |
| Q4 2018 | $389,000 | -45.3% | 29,956 | +0.8% | 0.00% | -100.0% |
| Q3 2018 | $711,000 | +25.0% | 29,730 | +0.1% | 0.00% | – |
| Q2 2018 | $569,000 | +55.9% | 29,702 | +0.7% | 0.00% | – |
| Q1 2018 | $365,000 | -69.4% | 29,505 | -69.7% | 0.00% | -100.0% |
| Q4 2017 | $1,193,000 | -10.5% | 97,505 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,333,000 | +82.1% | 97,505 | +105.3% | 0.00% | 0.0% |
| Q2 2017 | $732,000 | -16.2% | 47,505 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $874,000 | +228.6% | 47,505 | +61.0% | 0.00% | – |
| Q4 2016 | $266,000 | +13200.0% | 29,505 | +16291.7% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 180 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 180 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | -66.7% | 180 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | 0.0% | 180 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | +50.0% | 180 | 0.0% | 0.00% | – |
| Q2 2015 | $2,000 | 0.0% | 180 | 0.0% | 0.00% | – |
| Q1 2015 | $2,000 | 0.0% | 180 | +38.5% | 0.00% | – |
| Q2 2014 | $2,000 | – | 130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |